Ofloxacin + Dexamethasone Eye DropsThird Party Manufacturing in India

This combination eye drop delivers dual therapeutic action through two complementary mechanisms. Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and leading to bacterial cell death. It provides broad-spectrum coverage against gram-positive and gram-negative ocular pathogens. Dexamethasone, a potent corticosteroid, suppresses the inflammatory response by binding to glucocorticoid receptors inside target cells. This complex then translocates to the nucleus where it regulates gene transcription, reducing the production of pro-inflammatory mediators including prostaglandins, leukotrienes, and cytokines. Together, Ofloxacin treats the underlying bacterial infection while Dexamethasone rapidly controls the associated symptoms of redness, swelling, pain, and itching.

Therapeutic Uses

Ofloxacin + Dexamethasone Eye Drops are prescribed for:

• Steroid-Responsive Inflammatory Ocular Conditions: Where inflammation is accompanied by bacterial infection or risk of infection, including conjunctivitis, keratitis, blepharitis, and uveitis.
• Post-Operative Ocular Inflammation: Following cataract surgery or other ophthalmic procedures to prevent infection and control inflammation.
• Corneal Injuries: Chemical burns, radiation injuries, thermal burns, or penetration of foreign bodies where infection risk is elevated.

Why Manufacturers Choose Ofloxacin + Dexamethasone

Ofloxacin + Dexamethasone eye drops are one of the most prescribed ophthalmic combinations in India, available in 5ml and 10ml dropper bottles. The combination provides a complete therapeutic solution for inflamed, infected eyes in a single product, making it highly popular with ophthalmologists. For PCD franchise companies, this product offers strong brand loyalty and repeat prescription potential. Ofloxacin plus Dexamethasone third party manufacturing in India is a high-volume category with consistent demand across domestic and export markets for over two decades.